CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-05-05 | EcoR1 Capital, LLC 10% owner | Purchase | +1,062,736 | $29.02 | $30.8M | 11,584,280 |
| 2022-05-05 | EcoR1 Capital, LLC 10% owner | Sale | −1,062,736 | $29.02 | $30.8M | 11,584,280 |
| 2022-04-11 | Cooke Shane Director | Option exercise | +5,000 | $6.41 | $32K | 5,000 |
| 2022-04-11 | Cooke Shane Director | Sale | −3,002 | $34.48 | $104K | 1,998 |
| 2022-04-11 | Cooke Shane Director | Sale | −1,484 | $35.76 | $53K | 514 |
| 2022-04-11 | Cooke Shane Director | Sale | −514 | $36.60 | $19K | 0 |
| 2022-04-11 | Cooke Shane Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 45,000 | ||
| 2022-04-05 | COLLIER RICHARD T Director | Option exercise | +5,000 | $6.41 | $32K | 6,219 |
| 2022-04-05 | COLLIER RICHARD T Director | Sale | −2,631 | $39.18 | $103K | 3,588 |
| 2022-04-05 | COLLIER RICHARD T Director | Sale | −2,369 | $39.66 | $94K | 1,219 |
| 2022-04-05 | COLLIER RICHARD T Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 45,000 | ||
| 2022-02-23 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2022-02-23 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2020-04-08 | Nguyen Tran Chief Strategy Officer and CFO | Other disposition | −995 | 2,205 |
Page 28 of 28 · 555 trades